A Meta-Atlas of the Developing Human Cortex Identifies Modules Driving Cell Subtype Specification [Chimeroid]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 26 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 26 samples: 8 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE278573_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1167804 and SRA study SRP536114. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 18 samples.
How we read this: 8 replicated groups read from 26 sample titles; they account for 18 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8549477 Chimeroid cells, scram shRNA-treated and mCherry–, scRNAseq, tube 1 Chimeroid cells, scram …
- GSM8549478 Chimeroid cells, scram shRNA-treated and mCherry–, scRNAseq, tube 2 Chimeroid cells, scram …
- GSM8549479 Chimeroid cells, scram shRNA-treated and mCherry+, scRNAseq, tube 1 Chimeroid cells, scram …
- GSM8549480 Chimeroid cells, scram shRNA-treated and mCherry+, scRNAseq, tube 2 Chimeroid cells, scram …
- GSM8549481 Chimeroid cells, FEZF2 shRNA-treated and EGFP–, scRNAseq, tube 1 Chimeroid cells, FEZF2 …
- GSM8549482 Chimeroid cells, FEZF2 shRNA-treated and EGFP–, scRNAseq, tube 2 Chimeroid cells, FEZF2 …
- GSM8549483 Chimeroid cells, FEZF2 shRNA-treated and EGFP–, scRNAseq, tube 3 Chimeroid cells, FEZF2 …
- GSM8549484 Chimeroid cells, FEZF2 shRNA-treated and EGFP+, scRNAseq, tube 1 Chimeroid cells, FEZF2 …
- GSM8549485 Chimeroid cells, FEZF2 shRNA-treated and EGFP+, scRNAseq, tube 2 Chimeroid cells, FEZF2 …
- GSM8549486 Chimeroid cells, FEZF2 shRNA-treated and EGFP+, scRNAseq, tube 3 Chimeroid cells, FEZF2 …
- GSM8549487 Chimeroid cells, TSHZ3 shRNA-treated and mCherry–, scRNAseq, tube 1 Chimeroid cells, TSHZ3 …
- GSM8549488 Chimeroid cells, TSHZ3 shRNA-treated and mCherry–, scRNAseq, tube 2 Chimeroid cells, TSHZ3 …
- GSM8549489 Chimeroid cells, TSHZ3 shRNA-treated and mCherry+, scRNAseq, tube 1 Chimeroid cells, TSHZ3 …
- GSM8549490 Chimeroid cells, TSHZ3 shRNA-treated and mCherry+, scRNAseq, tube 2 Chimeroid cells, TSHZ3 …
- GSM8549491 Chimeroid cells, FEZF2 and TSHZ3 shRNA-treated and mCherry–;EGFP–, scRNAseq, tube 1 Chimeroid cells, FEZF2 …
- GSM8549492 Chimeroid cells, FEZF2 and TSHZ3 shRNA-treated and mCherry–;EGFP–, scRNAseq, tube 2 Chimeroid cells, FEZF2 …
- GSM8549493 Chimeroid cells, FEZF2 and TSHZ3 shRNA-treated and mCherry+;EGFP+, scRNAseq, tube 1 Chimeroid cells, FEZF2 …
- GSM8549494 Chimeroid cells, FEZF2 and TSHZ3 shRNA-treated and mCherry+;EGFP+, scRNAseq, tube 2 Chimeroid cells, FEZF2 …
- GSM8549495 Chimeroid cells, FEZF2 shRNA-treated and EGFP-, single-nuclei multi-ome (gene expression)
- GSM8549496 Chimeroid cells, FEZF2 shRNA-treated and EGFP+, single-nuclei multi-ome (gene expression)
- GSM8549497 Chimeroid cells, TSHZ3 shRNA-treated and mCherry-, single-nuclei multi-ome (gene expression)
- GSM8549498 Chimeroid cells, TSHZ3 shRNA-treated and mCherry+, single-nuclei multi-ome (gene expression)
- GSM8549499 Chimeroid cells, FEZF2 shRNA-treated and EGFP-, single-nuclei multi-ome (atac)
- GSM8549500 Chimeroid cells, FEZF2 shRNA-treated and EGFP+, single-nuclei multi-ome (atac)
- GSM8549501 Chimeroid cells, TSHZ3 shRNA-treated and mCherry-, single-nuclei multi-ome (atac)
- GSM8549502 Chimeroid cells, TSHZ3 shRNA-treated and mCherry+, single-nuclei multi-ome (atac)
- GSE62254 Molecular analysis of gastric cancer identifies discrete subtypes associated with distinct clinical characteristics and survival outcomes: the ACRG (Asian Cancer Research Group) study [gastric tumors] 300 samples shares identifies, subtype
- GSE318816 Blood-based Molecular Endotyping of Fibrotic Hypersensitivity Pneumonitis Identifies Two Immune Subtypes with Divergent Clinical Outcomes 126 samples shares identifies, subtype
- GSE319461 DNA methylation stochasticity is linked to transcriptional variability and identifies convergent epigenetic disruption across genetically-defined subtypes of AML 82 samples shares identifies, subtype
- GSE297483 Transcriptional stratification of necrotizing enterocolitis identifies distinct disease subtypes 23 samples shares identifies, subtype
- GSE338165 Single-cell analysis identifies monocyte signatures of disease activity and clinical subtypes in Behçet’s disease 22 samples shares identifies, subtype
- GSE310557 Multi-omics analysis identifies a microbiota–bile acid–TLR signaling axis driving bladder injury in interstitial cystitis 17 samples shares identifies, driving
- GSE319448 DNA methylation stochasticity is linked to transcriptional variability and identifies convergent epigenetic disruption across genetically-defined subtypes of AML [CellCulture_WGBS] 12 samples shares identifies, subtype
- GSE283621 Single-cell multi-omics analysis identifies metabolism-linked epigenetic reprogramming as a driver of therapy-resistant medulloblastoma 79 samples shares identifies
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.